Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Jan;136(1):81–94.

Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.

T T Casey 1, J B Cousar 1, M Mangum 1, M E Williams 1, J T Lee 1, J P Greer 1, R D Collins 1
PMCID: PMC1877457  PMID: 2297052

Abstract

Patients with Hodgkin's Disease (HD) occasionally develop monomorphic lymphomas in which mononuclear cells, usually large in size, grow in sheets, and in which there are few reacting cells or classic Reed-Sternberg (RS) cells. Twelve patients of this type were reviewed to determine the nature of the monomorphic growth. Paraffin-embedded tissue sections from the original diagnostic HD and the monomorphic growths were stained for Leu-M1 (CD15), leukocyte common antigen (LCA, CD45), pan B-cell markers LN1, LN2, and L26, and pan T-cell marker UCHL1 (CD45R) reactive in paraffin-embedded tissues. Cases were included only if the original diagnostic material had the classic histopathologic features of HD, if there was a separate monomorphic growth (in place or time), and if sufficient materials from both phases were available for study. Original diagnoses of HD included nodular sclerosing (NS; 8 cases); lymphocyte predominant (LP; 2 cases); mixed cellularity (MC; 1 case); and lymphocyte depleted (LD: 1 case) types. RS cells in the eight cases of NS HD and one case of MC HD were generally Leu-M1 and LN2 positive, and L26, LN1, UCHL1, and LCA negative. RS cells in one case of NS HD were LCA positive in addition to Leu-M1, LN1, and LN2. Two cases of NS HD showed L26 positive RS cells. Conversely, RS cells and lymphocytic-histiocytic (L and H) variants in the cases of LP HD were Leu-M1 and LN2 negative, and LCA and LN1 positive. The one case of LD HD possessed RS cells that were negative for Leu-M1, but positive for LCA, L26, LN1, and LN2. In seven cases (4 NS, 2 LP, 1 LD) the monomorphic growths possessed a B-cell phenotype (LCA, L26, and LN1 positive; Leu-M1 and UCHL1 negative). In the remaining cases (4 NS, 1 MC), the monomorphic growths were Leu-M1 positive, and displayed phenotypes similar to the RS cells of the original NS HD. Southern blot analysis was performed on the monomorphic components of five cases and showed some form of immunoglobulin gene rearrangement in each (4 cases: rearranged heavy chain-joining region gene; 1 case: rearranged Mu chain-constant region gene). Two of these cases expressed L26 and LN1 in the monomorphic phases. Despite apparent immunoglobulin gene rearrangement, one case expressed T-cell antigens Leu-4 (CD3) and Leu-1 (CD5), in addition to Leu-M1 (CD15).(ABSTRACT TRUNCATED AT 400 WORDS)

Full text

PDF
81

Images in this article

86Figure 1
on p.86
87Figure 2
on p.87
88Figure 3
on p.88
89Figure 4
on p.89
90Figure 5
on p.90
90Figure 6
on p.90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. O., Dick F. R., Goeken J. A., Foucar M. K., Gingrich R. D. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Arch Intern Med. 1983 Mar;143(3):445–450. [PubMed] [Google Scholar]
  2. Arseneau J. C., Canellos G. P., Johnson R., DeVita V. T., Jr Risk of new cancers in patients with Hodgkin's disease. Cancer. 1977 Oct;40(4 Suppl):1912–1916. doi: 10.1002/1097-0142(197710)40:4+<1912::aid-cncr2820400823>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  3. Baccarani M., Bosi A., Papa G. Second malignancy in patients treated by Hodgkin's disease. Cancer. 1980 Oct 15;46(8):1735–1740. doi: 10.1002/1097-0142(19801015)46:8<1735::aid-cncr2820460806>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Beckstead J. H. Optimal antigen localization in human tissues using aldehyde-fixed plastic-embedded sections. J Histochem Cytochem. 1985 Sep;33(9):954–958. doi: 10.1177/33.9.4020104. [DOI] [PubMed] [Google Scholar]
  5. Brinker M. G., Poppema S., Buys C. H., Timens W., Osinga J., Visser L. Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease. Blood. 1987 Jul;70(1):186–191. [PubMed] [Google Scholar]
  6. Brody R. S., Schottenfeld D., Reid A. Multiple primary cancer risk after therapy for Hodgkin's disease. Cancer. 1977 Oct;40(4 Suppl):1917–1926. doi: 10.1002/1097-0142(197710)40:4+<1917::aid-cncr2820400824>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  7. Burns B. F., Colby T. V., Dorfman R. F. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol. 1984 Apr;8(4):253–261. doi: 10.1097/00000478-198404000-00002. [DOI] [PubMed] [Google Scholar]
  8. Cartun R. W., Coles F. B., Pastuszak W. T. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol. 1987 Dec;129(3):415–421. [PMC free article] [PubMed] [Google Scholar]
  9. Casey T. T., Cousar J. B., Collins R. D. A simplified plastic embedding and immunohistologic technique for immunophenotypic analysis of human hematopoietic and lymphoid tissues. Am J Pathol. 1988 May;131(2):183–189. [PMC free article] [PubMed] [Google Scholar]
  10. Casey T. T., Olson S. J., Cousar J. B., Collins R. D. Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections. Blood. 1989 Dec;74(8):2624–2628. [PubMed] [Google Scholar]
  11. Casey T. T., Posey D. H., McCurley T. L. OKT4 epitope deficiency in significant proportions of the black population. A cause for underestimation of helper/suppressor lymphocyte ratios. Arch Pathol Lab Med. 1986 Aug;110(8):702–704. [PubMed] [Google Scholar]
  12. Caya J. G., Choi H., Tieu T. M., Wollenberg N. J., Almagro U. A. Hodgkin's disease followed by mycosis fungoides in the same patient. Case report and literature review. Cancer. 1984 Feb 1;53(3):463–467. doi: 10.1002/1097-0142(19840201)53:3<463::aid-cncr2820530316>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  13. Coleman C. N. Secondary neoplasms in patients treated for cancer: etiology and perspective. Radiat Res. 1982 Oct;92(1):188–200. [PubMed] [Google Scholar]
  14. Cousar J. B., McGinn D. L., Glick A. D., List A. F., Collins R. D. Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called "monocytoid" lymphocytes. Am J Clin Pathol. 1987 Jan;87(1):121–128. doi: 10.1093/ajcp/87.1.121. [DOI] [PubMed] [Google Scholar]
  15. Epstein A. L., Marder R. J., Winter J. N., Fox R. I. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J Immunol. 1984 Aug;133(2):1028–1036. [PubMed] [Google Scholar]
  16. Frierson H. F., Jr, Innes D. J., Jr Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease. Arch Pathol Lab Med. 1985 Nov;109(11):1024–1028. [PubMed] [Google Scholar]
  17. Ha-Kawa K., Hara J., Keiko Y., Muraguchi A., Kawamura N., Ishihara S., Doi S., Yabuuchi H. Kappa-chain gene rearrangement in an apparent T-lineage lymphoma. J Clin Invest. 1986 Dec;78(6):1439–1442. doi: 10.1172/JCI112733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jacquillat C., Khayat D., Desprez-Curely J. P., Weil M., Brocheriou C., Auclerc G., Chamseddine N., Bernard J. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature. Cancer. 1984 Feb 1;53(3):459–462. doi: 10.1002/1097-0142(19840201)53:3<459::aid-cncr2820530315>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  19. Kadin M. E. Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet. 1985 Oct 19;2(8460):864–865. doi: 10.1016/s0140-6736(85)90128-x. [DOI] [PubMed] [Google Scholar]
  20. Kadin M. E., Muramoto L., Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol. 1988 Feb;130(2):345–353. [PMC free article] [PubMed] [Google Scholar]
  21. Kadin M. E. Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep. 1982 Apr;66(4):601–608. [PubMed] [Google Scholar]
  22. Kim H. D., Bedetti C. D., Boggs D. R. The development of non-Hodgkin's lymphoma following therapy for Hodgkin's disease. Cancer. 1980 Dec 15;46(12):2596–2602. doi: 10.1002/1097-0142(19801215)46:12<2596::aid-cncr2820461211>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  23. Kim H., Dorfman R. F. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas. Cancer. 1974 Mar;33(3):657–674. doi: 10.1002/1097-0142(197403)33:3<657::aid-cncr2820330311>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  24. Knowles D. M., 2nd, Neri A., Pelicci P. G., Burke J. S., Wu A., Winberg C. D., Sheibani K., Dalla-Favera R. Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7942–7946. doi: 10.1073/pnas.83.20.7942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Krikorian J. G., Burke J. S., Rosenberg S. A., Kaplan H. S. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med. 1979 Mar 1;300(9):452–458. doi: 10.1056/NEJM197903013000902. [DOI] [PubMed] [Google Scholar]
  26. Linder J., Ye Y. L., Harrington D. S., Armitage J. O., Weisenburger D. D. Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. Am J Pathol. 1987 Apr;127(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  27. List A. F., Greer J. P., Cousar J. B., Stein R. S., Flexner J. M., Sinangil F., Davis J., Volsky D. J., Purtilo D. T. Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virus. Ann Intern Med. 1986 Nov;105(5):668–673. doi: 10.7326/0003-4819-105-5-668. [DOI] [PubMed] [Google Scholar]
  28. Lukes R. J. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res. 1971 Nov;31(11):1755–1767. [PubMed] [Google Scholar]
  29. Marder R. J., Variakojis D., Silver J., Epstein A. L. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections. Lab Invest. 1985 May;52(5):497–504. [PubMed] [Google Scholar]
  30. Miettinen M., Franssila K. O., Saxén E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer. 1983 Jun 15;51(12):2293–2300. doi: 10.1002/1097-0142(19830615)51:12<2293::aid-cncr2820511221>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  31. Nelson D. F., Cooper S., Weston M. G., Rubin P. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy. Cancer. 1981 Dec 1;48(11):2386–2393. doi: 10.1002/1097-0142(19811201)48:11<2386::aid-cncr2820481109>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  32. Okon E., Felder B., Epstein A., Lukes R. J., Taylor C. R. Monoclonal antibodies reactive with B-lymphocytes and histiocytes in paraffin sections. Cancer. 1985 Jul 1;56(1):95–104. doi: 10.1002/1097-0142(19850701)56:1<95::aid-cncr2820560116>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  33. Pinkus G. S., Kurtin P. J. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol. 1985 Sep;16(9):929–940. doi: 10.1016/s0046-8177(85)80132-5. [DOI] [PubMed] [Google Scholar]
  34. Pinkus G. S., Said J. W. Leu-M1 immunoreactivity in nonhematopoietic neoplasms and myeloproliferative disorders. An immunoperoxidase study of paraffin sections. Am J Clin Pathol. 1986 Mar;85(3):278–282. doi: 10.1093/ajcp/85.3.278. [DOI] [PubMed] [Google Scholar]
  35. Pinkus G. S., Thomas P., Said J. W. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol. 1985 May;119(2):244–252. [PMC free article] [PubMed] [Google Scholar]
  36. Poppema S., Kaiserling E., Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology. 1979 Jul;3(4):295–308. doi: 10.1111/j.1365-2559.1979.tb03011.x. [DOI] [PubMed] [Google Scholar]
  37. Poppema S. The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem. 1980 Aug;28(8):788–791. doi: 10.1177/28.8.6777426. [DOI] [PubMed] [Google Scholar]
  38. Reed K. C., Mann D. A. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 1985 Oct 25;13(20):7207–7221. doi: 10.1093/nar/13.20.7207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rovigatti U., Mirro J., Kitchingman G., Dahl G., Ochs J., Murphy S., Stass S. Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia. Blood. 1984 May;63(5):1023–1027. [PubMed] [Google Scholar]
  40. Schomberg P. J., Evans R. G., Banks P. M., White W. L., O'Connell M. J., Earle J. D. Second malignant lesions after therapy for Hodgkin's disease. Mayo Clin Proc. 1984 Jul;59(7):493–497. doi: 10.1016/s0025-6196(12)60440-6. [DOI] [PubMed] [Google Scholar]
  41. Sheibani K., Battifora H., Burke J. S., Rappaport H. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Surg Pathol. 1986 Apr;10(4):227–236. doi: 10.1097/00000478-198604000-00001. [DOI] [PubMed] [Google Scholar]
  42. Sheibani K., Wu A., Ben-Ezra J., Stroup R., Rappaport H., Winberg C. Rearrangement of kappa-chain and T-cell receptor beta-chain genes in malignant lymphomas of "T-cell" phenotype. Am J Pathol. 1987 Nov;129(2):201–207. [PMC free article] [PubMed] [Google Scholar]
  43. Sherrod A. E., Felder B., Levy N., Epstein A., Marder R., Lukes R. J., Taylor C. R. Immunohistologic identification of phenotypic antigens associated with Hodgkin and Reed-Sternberg cells. A paraffin section study. Cancer. 1986 Jun 1;57(11):2135–2140. doi: 10.1002/1097-0142(19860601)57:11<2135::aid-cncr2820571109>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  44. Siminovitch K. A., Bakhshi A., Goldman P., Korsmeyer S. J. A uniform deleting element mediates the loss of kappa genes in human B cells. Nature. 1985 Jul 18;316(6025):260–262. doi: 10.1038/316260a0. [DOI] [PubMed] [Google Scholar]
  45. Stein H., Uchánska-Ziegler B., Gerdes J., Ziegler A., Wernet P. Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer. 1982 Mar 15;29(3):283–290. doi: 10.1002/ijc.2910290310. [DOI] [PubMed] [Google Scholar]
  46. Strickler J. G., Michie S. A., Warnke R. A., Dorfman R. F. The "syncytial variant" of nodular sclerosing Hodgkin's disease. Am J Surg Pathol. 1986 Jul;10(7):470–477. doi: 10.1097/00000478-198607000-00004. [DOI] [PubMed] [Google Scholar]
  47. Sundeen J., Lipford E., Uppenkamp M., Sussman E., Wahl L., Raffeld M., Cossman J. Rearranged antigen receptor genes in Hodgkin's disease. Blood. 1987 Jul;70(1):96–103. [PubMed] [Google Scholar]
  48. Swerdlow S. H., Wright S. A. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations. Am J Clin Pathol. 1986 Mar;85(3):283–288. doi: 10.1093/ajcp/85.3.283. [DOI] [PubMed] [Google Scholar]
  49. Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest. 1986 Apr;54(4):457–461. [PubMed] [Google Scholar]
  50. Weiss L. M., Strickler J. G., Hu E., Warnke R. A., Sklar J. Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol. 1986 Oct;17(10):1009–1014. doi: 10.1016/s0046-8177(86)80084-3. [DOI] [PubMed] [Google Scholar]
  51. Wieczorek R., Burke J. S., Knowles D. M., 2nd Leu-M1 antigen expression in T-cell neoplasia. Am J Pathol. 1985 Dec;121(3):374–380. [PMC free article] [PubMed] [Google Scholar]
  52. Williams M. E., Innes D. J., Jr, Borowitz M. J., Lovell M. A., Swerdlow S. H., Hurtubise P. E., Brynes R. K., Chan W. C., Byrne G. E., Jr, Whitcomb C. C. Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia. Blood. 1987 Jan;69(1):79–86. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES